We here show that the p53 and p63 proteoforms with substantial differences in their primary sequences and their 3D structure in comparison with the canonical proteins possess, not only differential seroreactivity but also, for some proteoforms, a higher diagnostic ability to distinguish CRC patients and colorectal premalignant individuals from healthy individuals. This evidence concerns the gene TP63 and colorectal carcinoma.